The introduction of bortezomib, a novel first-in-class proteasome inhibitor, has been a major
break through in the treatment of multiple myeloma. It is currently approved for the treatment …

Care of people in their last days of life should be based on compassion, respect and, wherever
possible, on research evidence. Previously the Liverpool Care Pathway attempted to …

… Joshua Ruegger research fellow1, Sarah Hodgkinson senior research fellow1, Antonia
Field-Smith … The technical team at the National Clinical Guideline Centre included Kate …

A patient’s preferred place of death (PPD) is frequently used as a marker for quality of end
of life care. However, surveys of patients with life-limiting conditions indicate that “dying in …

The COVID-19 pandemic has presented innumerable clinical and non-clinical challenges.
The global healthcare community has responded with a tsunami of guidelines as the world …

Abstracts Page 1 Participants described the transition period as a difficult time for both the
YP and their families, with a perceived lack of adult services available for them. All groups …

Background A scoping exercise and literature review of national and local initiatives highlighted
innovation and evaluation as critical elements of change within the healthcare system, …

Background There are increasing numbers of young people (YP) with life limiting diagnoses
living into adulthood. When these YP become too old for children’s hospice services there is …

Nausea and vomiting in palliative care are commonly experienced symptoms, and the
aetiology is often multifactorial. The most common causes are impaired gastric emptying, …

Until just a few months ago, intensive care units (ICUs) were typically much less restrictive
about visiting than other wards–it would have been unthinkable to deny relatives the chance …